These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]. Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625 [TBL] [Abstract][Full Text] [Related]
25. [Interferon alfa in the treatment of hairy cell leukemia]. Adam Z Vnitr Lek; 1994 Mar; 40(3):199-202. PubMed ID: 8184577 [TBL] [Abstract][Full Text] [Related]
26. Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Magee MJ; McKenzie S; Filippa DA; Arlin ZA; Gee TS; Clarkson BD Cancer; 1985 Dec; 56(11):2557-62. PubMed ID: 4052933 [TBL] [Abstract][Full Text] [Related]
27. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia. Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231 [TBL] [Abstract][Full Text] [Related]
28. Hairy-cell leukemia and alpha-interferon treatment: long-term responders. Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317 [TBL] [Abstract][Full Text] [Related]
29. Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL). Capnist G; Federico M; Chisesi T; Resegotti L; Lamparelli T; Fabris P; Rossi G; Invernizzi R; Guarnaccia C; Leoni P Leuk Lymphoma; 1994 Aug; 14(5-6):457-64. PubMed ID: 7812205 [TBL] [Abstract][Full Text] [Related]
31. The treatment of hairy cell leukemia with alpha 2b-interferon: experience with 27 patients treated more than one year. Thompson JA; Rubin E; Fefer A Leukemia; 1987 Apr; 1(4):328-30. PubMed ID: 3669756 [TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukaemia: the role of alpha interferon. Platanias LC; Ratain MJ Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481 [TBL] [Abstract][Full Text] [Related]
34. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181 [TBL] [Abstract][Full Text] [Related]
35. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL). Damasio EE; Frassoldati A Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061 [TBL] [Abstract][Full Text] [Related]
36. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy. Ehmann WC; Silber R Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508 [TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061 [TBL] [Abstract][Full Text] [Related]
38. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases. Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545 [TBL] [Abstract][Full Text] [Related]
39. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon. Holmes R; Schwarz MA; Whiteside MG; Firkin FC Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242 [TBL] [Abstract][Full Text] [Related]